3D Scanning Enables Earlier Melanoma Detection
|
By MedImaging International staff writers Posted on 30 Sep 2021 |

Image: A 3-D fully body imaging scanner can map the entire body in one second (Photo courtesy of ACEMID)
The Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACEMID; Brisbane, Australia), a collaboration between the University of Queensland (UQ; Brisbane, Australia), the University of Sydney (US; Australia), and Monash University (Melbourne, Australia) is the basis for a new national network of interconnected 3D full body scanning and mapping systems that can help track moles and skin spots over time.
The telemedicine network will allow dermatologists and medical professionals to detect skin cancers remotely, across Australia. Medical researchers will be able to immediately access a database of up to 100,000 patient images taken by the 3D full body imaging systems located in the Queensland, New South Wales (NSW), and Victoria. Using algorithms created by artificial intelligence (AI), the 3D imaging systems can analyze the images and produce a full body skin spot map, which can be used to monitor patients over time.
“Australia has the highest rates of melanoma in the world, with an average 28,000 Australians diagnosed with the disease every year,” said UQ dermatologist Professor H. Peter Soyer, MD. “This technology is revolutionizing early melanoma detection using 3D state-of-the-art body imaging systems that take an image in milliseconds, making it a game-changer for melanoma detection.”
“Australia has the deadliest form of melanoma, for which there is currently no standardized diagnosis. Clinical trials and cohort studies are crucial sources of evidence for the improvement of health and healthcare,” said Greg Hunt, Australian Minister for Health and Aged Care. “Cutting-edge, total-body 3D imaging machines across metropolitan and regional Queensland, NSW, and Victoria, will help to discover more effective diagnosis options for thousands of Australians who are tested for skin cancer each year.”
Melanoma is a malignant tumor of melanocytes, the cells that produce the dark pigment, melanin, which is responsible for the color of skin. They predominantly occur in skin, but are also found in other parts of the body, including the bowel and the eye. Melanoma is less common than other skin cancers. However, it is much more dangerous and causes the majority (75%) of deaths related to skin cancer. Treatment includes surgical removal of the tumor, adjuvant treatment, chemo- and immunotherapy, or radiation therapy.
Related Links:
Australian Centre of Excellence in Melanoma Imaging and Diagnosis
University of Queensland
University of Sydney
Monash University
The telemedicine network will allow dermatologists and medical professionals to detect skin cancers remotely, across Australia. Medical researchers will be able to immediately access a database of up to 100,000 patient images taken by the 3D full body imaging systems located in the Queensland, New South Wales (NSW), and Victoria. Using algorithms created by artificial intelligence (AI), the 3D imaging systems can analyze the images and produce a full body skin spot map, which can be used to monitor patients over time.
“Australia has the highest rates of melanoma in the world, with an average 28,000 Australians diagnosed with the disease every year,” said UQ dermatologist Professor H. Peter Soyer, MD. “This technology is revolutionizing early melanoma detection using 3D state-of-the-art body imaging systems that take an image in milliseconds, making it a game-changer for melanoma detection.”
“Australia has the deadliest form of melanoma, for which there is currently no standardized diagnosis. Clinical trials and cohort studies are crucial sources of evidence for the improvement of health and healthcare,” said Greg Hunt, Australian Minister for Health and Aged Care. “Cutting-edge, total-body 3D imaging machines across metropolitan and regional Queensland, NSW, and Victoria, will help to discover more effective diagnosis options for thousands of Australians who are tested for skin cancer each year.”
Melanoma is a malignant tumor of melanocytes, the cells that produce the dark pigment, melanin, which is responsible for the color of skin. They predominantly occur in skin, but are also found in other parts of the body, including the bowel and the eye. Melanoma is less common than other skin cancers. However, it is much more dangerous and causes the majority (75%) of deaths related to skin cancer. Treatment includes surgical removal of the tumor, adjuvant treatment, chemo- and immunotherapy, or radiation therapy.
Related Links:
Australian Centre of Excellence in Melanoma Imaging and Diagnosis
University of Queensland
University of Sydney
Monash University
Latest General/Advanced Imaging News
- Virtual Staining Technique Creates Histology Images from CT Data
- CT-Derived Biomarker Predicts Outcomes in Gastric Cancer
- AI Tool Enhances Response Assessment and Survival Prediction in Pleural Mesothelioma
- AI Tool Enables Real-Time Diffuse Optical Tomography for Brain Lesion Detection
- New SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease
- Whole-Body PET/CT Tracks Metabolic Changes After Bariatric Surgery
- PET Tracer Localizes Overactive Adrenal Glands in Primary Aldosteronism
- Multimodal AI Tool Combines CT and Health Records to Predict Heart Risk
- AI Tool Automates Radiotherapy Planning for Cervical and Prostate Cancer
- New Proton Therapy Platform Integrates into Existing Radiotherapy Departments
- 3D-Printed Intraoral Device Enhances Head and Neck Radiotherapy Accuracy
- Molecular Imaging Agent Shows Promise for Endometriosis Detection and Monitoring
- Automated AI Tool Detects Early Pancreatic Cancer on Routine CT
- Routine Cardiac CT Enhanced to Predict Heart Failure Risk
- New Breast Imaging Viewer Unifies Modalities and Enhances Clinical Workflow
- Radiomics Analysis of CT Scans Enhances Evaluation of Sarcoidosis
Channels
Radiography
view channel
AI Tool Predicts Five-Year Breast Cancer Risk from Mammograms
Breast cancer risk assessment during routine screening is difficult because many women who develop the disease have no known genetic mutations or family history. Static risk tools provide limited discrimination... Read more
AI Mammography Tools Detect Early Breast Cancer Signs Years Before Diagnosis
Breast cancer screening aims to detect tumors before symptoms develop, but subtle mammographic changes can appear years before diagnosis and may be missed during routine reads. Delayed detection can lead... Read moreMRI
view channel
AI Reconstruction Tool Speeds Dynamic Breast MRI and Improves Cancer Detection
Breast cancer affects about 2.3 million people each year, creating sustained demand for precise imaging. Dynamic magnetic resonance imaging (MRI) is highly sensitive, yet slow acquisitions hinder real-time... Read more
International Study Assesses AI for Prostate Cancer MRI Interpretation
Prostate cancer is a leading cause of cancer morbidity in men, and accurate early diagnosis hinges on expert interpretation of prostate magnetic resonance imaging (MRI). Rapid adoption of MRI-first pathways... Read moreUltrasound
view channel
AI Ultrasound Platform Receives CE Mark for Prenatal Screening
Prenatal ultrasound is central to fetal anomaly screening, yet it remains one of the most technically demanding examinations in routine care. Because both image acquisition and interpretation are highly... Read more
Hybrid Imaging Platform Reveals How Sleep Supports Brain Waste Removal
The brain’s glymphatic system clears metabolic waste via cerebrospinal fluid and is thought to support neural health during sleep. Yet clinicians and researchers have struggled to observe its whole‑brain... Read moreNuclear Medicine
view channelNew PET Tracer Detects DVT and Pulmonary Embolism in One Scan
Deep vein thrombosis is the formation of clots in deep leg veins that can migrate to the lungs as pulmonary embolism. Rapid confirmation across both regions often requires multiple tests and can delay treatment.... Read more
Targeted PET Platform Guides Osteosarcoma Resection and Margin Verification
Osteosarcoma, an aggressive primary bone cancer that mainly affects children and adolescents, demands wide excision to prevent local recurrence. Surgeons must achieve negative margins while preserving... Read moreImaging IT
view channel
Ambient AI Reporting Platform Streamlines Radiology Reporting
Radiology departments face growing imaging volumes and staffing shortages, creating reporting bottlenecks and pressure to maintain turnaround times. Conventional dictation tools document findings after... Read more
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read moreIndustry News
view channel
GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







